Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

98.82
+1.451.49%
Post-market: 98.820.00000.00%19:30 EDT
Volume:937.61K
Turnover:92.48M
Market Cap:6.42B
PE:-7.02
High:100.50
Open:99.53
Low:97.26
Close:97.37
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:1.36
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-615.68
PE(LYR):-210.26

Loading ...

Apr 08, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 09, 2022

Major Issues Report

8-K - Current report
Mar 09, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2022

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report
Nov 19, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 25, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 29, 2021

Major Issues Report

8-K - Current report
Aug 24, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 20, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report